Evidence map›Paper›PMID 35192546›Full record

ArticleThe Journal of clinical investigation2022

Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression.

Colin Valet, Mélia Magnen, Longhui Qiu, Simon J Cleary, Kristin M Wang, Serena Ranucci, Elodie Grockowiak, Rafik Boudra, Catharina Conrad, Yurim Seo and 7 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 91 citations in OpenAlex.

  1. Intrahepatic Platelets Orchestrate Microenvironmental Remodelling and Cellular Crosstalk in Liver Fibrosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. The lung tissue environment inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Platelet effector functions in inflammation.Research and practice in thrombosis and haemostasis · 2026
    Review
  10. Article
  11. Article
  12. Platelet Disorders and Medication Strategies.Thrombosis and haemostasis · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Splenic PD-L1Research (Washington, D.C.) · 2026
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Colin ValetDepartment of Medicine, UCSF, San Francisco, California, USA.
Mélia MagnenDepartment of Medicine, UCSF, San Francisco, California, USA.
Longhui QiuDepartment of Medicine, UCSF, San Francisco, California, USA.
Simon J ClearyDepartment of Medicine, UCSF, San Francisco, California, USA.
Kristin M WangDepartment of Medicine, UCSF, San Francisco, California, USA.
Serena RanucciDepartment of Medicine, UCSF, San Francisco, California, USA.
Elodie GrockowiakWellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Rafik BoudraDepartment of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Catharina ConradDepartment of Medicine, UCSF, San Francisco, California, USA.
Yurim SeoDepartment of Medicine, UCSF, San Francisco, California, USA.
Daniel R CalabreseDepartment of Medicine, UCSF, San Francisco, California, USA.
John R GreenlandDepartment of Medicine, UCSF, San Francisco, California, USA.
Andrew D LeavittDepartment of Medicine, UCSF, San Francisco, California, USA.
Emmanuelle PasseguéColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University Irving Medical Center, New York, New York, USA.
Simón Méndez-FerrerWellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Filip K SwirskiCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mark R LooneyDepartment of Medicine, UCSF, San Francisco, California, USA.
University of California, San Francisco · USBrigham and Women's Hospital · USColumbia University Irving Medical Center · USIcahn School of Medicine at Mount Sinai · USNHS Blood and Transplant · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Immunobiology of the normal and injured lungR35HL161241 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARK ROBERTS LOONEY · 2022 to 2026
$4.2M
Immunomodulation by splenic megakaryocytes and platelets in sepsisR01AI165919 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2022 to 2025
$3.2M
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular trapsR01AI160167 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2021 to 2025
$3.1M
Telomere Dysfunction as a cause of Chronic Lung Allograft DysfunctionR01HL151552 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENLAND, JOHN · 2020 to 2024
$1.6M
Natural killer cells in pulmonary ischemia-reperfusion injuryIK2BX005301 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI Daniel Calabrese · 2021 to 2026
–
BLRD VA IK2 BX005301Cancer Research UK 26670Cancer Research UK C61367/A26670Medical Research Council MC_PC_17230Medical Research Council MR/V005421/1NHLBI NIH HHS R01 HL151552NHLBI NIH HHS R35 HL161241NIAID NIH HHS R01 AI160167NIAID NIH HHS R01 AI165919
6 · The paper itself

Abstract

Platelets have a wide range of functions including critical roles in hemostasis, thrombosis, and immunity. We hypothesized that during acute inflammation, such as in life-threatening sepsis, there are fundamental changes in the sites of platelet production and phenotypes of resultant platelets. Here, we showed during sepsis that the spleen was a major site of megakaryopoiesis and platelet production. Sepsis provoked an adrenergic-dependent mobilization of megakaryocyte-erythrocyte progenitors (MEPs) from the bone marrow to the spleen, where IL-3 induced their differentiation into megakaryocytes (MKs). In the spleen, immune-skewed MKs produced a CD40 ligandhi platelet population with potent immunomodulatory functions. Transfusions of post-sepsis platelets enriched from splenic production enhanced immune responses and reduced overall mortality in sepsis-challenged animals. These findings identify a spleen-derived protective platelet population that may be broadly immunomodulatory in acute inflammatory states such as sepsis.

Indexed as

Blood PlateletsSepsisAnimalsCD40 LigandMegakaryocytesSpleenCD40 LigandHematologyHematopoietic stem cellsInnate immunityPlateletsStem cells

Identifiers

PMID35192546
PMCPMC8970674
OpenAlexW4213009913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.